FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 1043100 · Received May 8, 2008

Report

Report Number
2124215-2008-33545
Event Type
Injury
Date Received
May 8, 2008
Date of Event
February 15, 2008
Report Date
October 20, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
LAY USER/PATIENT

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. THE COMPLETE LEAD WAS RETURNED, WITH DRIED BLOOD NOTED IN THE LUMEN OF THE LEAD AND TERMINAL PIN OPENING. RESISTANCE AND PRESSURE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, LEAD BODY, AND ELECTRODE TIP FOUND NO ANOMALIES. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS AND DETAILED ANALYSIS DID NOT REVEAL ANY ABNORMALITIES.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT 3 YEARS AGO, THIS RIGHT ATRIAL (RA) LEAD WAS SURGICALLY ABANDONED DUE TO INAPPROPRIATE ATRIAL PACING DUE TO ATRIAL UNDERSENSING, AS WELL AS HIGH IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. RECENTLY, THIS LEAD WAS EXPLANTED DURING AN UNRELATED PROCEDURE AND RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4087 NA

Patients

Seq Age Sex Outcome Treatment
1 75 YR Hospitalization| L| O| R THE DEVICE (B)(4) WAS IMPLANTED| THE DEVICE 4088/154158 WAS IMPLANTED 22-APR-2003| THE DEVICE (B)(4) WAS IMPLANTED| THE DEVICE 1294/101234 WAS IMPLANTED 22-APR-2003